LSBCF — LakeShore Biopharma Co Share News
0.000.00%
Last trade - 00:00- $2.76m
- $59.77m
- CNY614.96m
Brief: Ys Biopharma - Phase 3 Clinical Trial Planned To Commence Later In 2023
U.S. STOCKS ON THE MOVE-Applied Digital, Amdocs, First Watch
U.S. STOCKS ON THE MOVE-Shake Shack, Western Alliance, Blue Apron
YS Biopharma up as its rabies vaccine gets late-stage trial approval in Pakistan
Brief: YS Biopharma Phase 3 Clinical Trial Will Evaluate Immunogenicity Of Co's Pika Rabies Vaccine
Brief: Ys Biopharma Announces Record Vaccine Revenues And Preliminary Financial Results For Fy2023 Ended March 31, 2023
U.S. STOCKS ON THE MOVE-Energy firms, crypto stocks, Walt Disney
U.S. STOCKS ON THE MOVE-Cyclerion, banks, Jounce Therapeutics
U.S. STOCKS ON THE MOVE-Tesla, BrainStorm, Pinterest
YS Biopharma rises on positive interim data from COVID vaccine study
Brief: YS Biopharma's PIKA Recombinant Covid-19 Vaccine Shows Superior Antibody Neutralization Responses Versus Inactivated Covid Vaccine In Phase II Head-To-Head Study
Brief: Ys Biopharma And Summit Healthcare Announce Shareholder Approval Of Business Combination
Brief: Summit Healthcare And YS Biopharma Announce Effectiveness Of Registration Statement And Extraordinary General Meeting Date For Proposed Business Combination
Brief: Summit Healthcare Acquisition Corp- Received Nasdaq Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard On Jan 11
Brief: YS Biopharma To Merge With Nasdaq-Listed Summit Healthcare Acquisition Corp